Warner Bros. may reopen sale talks with Paramount following new deal terms, Bloomberg reports

Warner Bros. may reopen sale talks with Paramount following new deal terms, Bloomberg reports


The Warner Bros. logo is displayed on a water tower at Warner Bros. Studio on September 12, 2025 in Burbank, California.

Mario Tama | Getty Images

Warner Bros. Discovery‘s board is considering reopening sales talks with Paramount Skydance after recently receiving an amended offer with sweetened deal terms, Bloomberg News reported on Sunday, citing unnamed sources.

Warner Bros. in December agreed to sell both its film studio and HBO Max streaming service to Netflix for $27.75 per share. Paramount, which owns CBS and MTV, in December launched a hostile bid for Warner Bros., promising its shareholders $30 per share in an all-cash deal.

Last week, Paramount upped the ante, saying it would add a ticking fee of 25 cents a share to its offer for any delay in regulatory approval of the deal.

The ticking fee would be approximately $650 million in cash value per quarter for every quarter the deal has not closed by Dec. 31, 2026, CNBC.com previously reported.

Paramount also said it will cover a $2.8 billion termination fee paid to Netflix if the Warner Bros. deal is terminated. Paramount also said it will eliminate $1.5 billion in possible debt refinancing costs.

Both Paramount and Netflix have said they would be willing to raise their bids to secure the Warner Bros. deal, Bloomberg reported. However, this is the first time Warner Bros. has considered whether Paramount’s offer could either result in a better deal or prompt Netflix to offer better deal terms, according to the report.

Read the complete Bloomberg report here.

WATCH: Chadwick: This is a once-in-a-lifetime opportunity for Paramount

Chadwick: This is a once in a lifetime opportunity for Paramount



Source

Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More
JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets
World

JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets

Jamie Dimon, Chairman and CEO, JPMorganChase, speaks during the Reagan National Defense Forum at the Ronald Reagan Presidential Library in Simi Valley, California, U.S. December 6, 2025. Jonathan Alcorn | Reuters JPMorgan Chase CEO Jamie Dimon is calling for a broad recommitment to American ideals as his bank navigates geopolitical uncertainty, a teetering economy and […]

Read More
US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut
World

US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut

Smoke rises after explosions struck the northeastern, western, and central areas amid Israeli attacks in Tehran, Iran on April 1, 2026. Tolga Akbaba | Anadolu | Getty Images The United States and Iran received the framework of a plan to end hostilities, but Iran rejected immediately reopening the Strait of Hormuz, after President Donald Trump […]

Read More